Skip to content

Precigen PGEN Tax on Share Settlement

Tax on Share Settlement at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$73.2M+1,602%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$4.07M+129%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.93B+213%

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's tax on share settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's tax on share settlement?
Precigen (PGEN) reported tax on share settlement of $146K in Q1 2026.
How has Precigen's tax on share settlement changed year-over-year?
Precigen's tax on share settlement decreased by 69.2% year-over-year, from $474K to $146K.
What does tax on share settlement mean?
Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.